Returns
Every filed return on the register. Filter, then open any return on lobbying.ie to read it in full.
Showing returns filed by Pfizer naming James Lawless .
Filed returns
11
match these filters
| Period | Registrant | Policy area | Subject, as filed | Officials named | Link |
|---|---|---|---|---|---|
| Jan–Apr 2018 | Pfizer | Taxation | Global competition for FDI and life sciences investment continues to intensify and Ireland continues to compete for such investment. Pfizer has extensive operations in Ireland where many of Pfizer's leading and newest… (Public policy or programme) | 21 | On lobbying.ie |
| Sep–Dec 2017 | Pfizer | Health | Pfizer is seeking reimbursement for a new treatment for metatastic breast cancer which is reimbursed in the majority of EU countries but not yet in Ireland. Ireland has become one of the slowest countries in Europe to… (Public policy or programme) | 5 | On lobbying.ie |
| Sep–Dec 2017 | Pfizer | Health | Pfizer launched 'MBC: A Call to Action' to highlight the unmet needs of metastatic breast cancer patients. MBC is an advanced form of breast cancer where early detection does not improve survival. Even if diagnosed with… (Public policy or programme) | 14 | On lobbying.ie |
| May–Aug 2017 | Pfizer | Health | Pfizer is seeking reimbursement for a new treatment for metastatic breast cancer. Metastatic breast cancer is an advanced form of breast cancer where early detection unfortunately does not improve survival. Even if… (Public policy or programme) | 1 | On lobbying.ie |
| Jan–Apr 2017 | Pfizer | Health | A Supply Agreement was negotiated in 2016 between the pharmaceutical industry and the state which provides 785m in savings over four years, ensures Irish on patent medicine prices are in line with 14 other EU countries… (Public policy or programme) | 7 | On lobbying.ie |
| Jan–Apr 2017 | Pfizer | Economic Development and Industry | Global competition for FDI and life sciences investment continues to intensify and Ireland continues to compete for such investment. Pfizer has extensive operations in Ireland where many of Pfizer's leading and newest… (Public policy or programme) | 7 | On lobbying.ie |
| Jan–Apr 2017 | Pfizer | Health | Pfizer is seeking reimbursement for a new treatment for metastatic breast cancer. Metastatic breast cancer is an advanced form of breast cancer where early detection unfortunately does not improve survival. Even if… (Matters involving public funds) | 8 | On lobbying.ie |
| Sep–Dec 2016 | Pfizer | Health | Metastatic breast cancer is an advanced form of breast cancer where early detection unfortunately does not improve survival. Even if diagnosed with early stage breast cancer, 30% of women will subsequently progress to… (Public policy or programme) | 6 | On lobbying.ie |
| Sep–Dec 2016 | Pfizer | Health | A Supply Agreement was negotiated in 2016 between the pharmaceutical industry and the state which provides 785m in savings over four years, ensures Irish on patent medicine prices are in line with 14 other EU countries (Public policy or programme) | 6 | On lobbying.ie |
| Sep–Dec 2016 | Pfizer | Taxation | Ireland has maintained a competitive corporate tax framework which is critical for international investment and this has become the subject of global and national debate and dialogue (Public policy or programme) | 6 | On lobbying.ie |
| Sep–Dec 2016 | Pfizer | Health | The Health (pricing and supply of medical goods) Act 2013 states that biologic medicines are out of scope for interchangeability. Biologic medicines are typically infusions and injections for diseases such as rheumatoid… (Legislation) | 5 | On lobbying.ie |
Policy areas in these returns
| Public policy area | Filed returns | Share | Relative to the largest |
|---|---|---|---|
| Health | 8 | 72.7% | |
| Taxation | 2 | 18.2% | |
| Economic Development and Industry | 1 | 9.1% |